BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26935349)

  • 1. Pharmacokinetics of tildipirosin in pig tonsils.
    Torres F; Santamaria R; Jimenez M; Menjón R; Ibanez A; Collell M; Azlor O; Fraile L
    J Vet Pharmacol Ther; 2016 Apr; 39(2):199-201. PubMed ID: 26935349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae.
    Rose M; Menge M; Bohland C; Zschiesche E; Wilhelm C; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M
    J Vet Pharmacol Ther; 2013 Apr; 36(2):140-53. PubMed ID: 22500881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep.
    Abu-Basha EA; Bani Ismail Z; Abu Alhaijaa H; Hamzeh E; Idkaidek NM
    J Vet Pharmacol Ther; 2021 Jan; 44(1):79-85. PubMed ID: 32748450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle).
    Menge M; Rose M; Bohland C; Zschiesche E; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M
    J Vet Pharmacol Ther; 2012 Dec; 35(6):550-9. PubMed ID: 22188102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of tildipirosin in rabbits following single-dose intravenous and intramuscular administration.
    Xiong J; Xu Y; He S; Zhang Y; Wang Z; Wang S; Jiang H
    J Vet Pharmacol Ther; 2020 Sep; 43(5):448-453. PubMed ID: 32542744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marbofloxacin reaches high concentration in pig tonsils in a dose-dependent fashion.
    Vilalta C; Schneider M; López-Jimenez R; Caballero JM; Gottschalk M; Fraile L
    J Vet Pharmacol Ther; 2011 Feb; 34(1):95-7. PubMed ID: 21219353
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of tildipirosin in beagle dogs.
    Wang J; Zhao T; Sun X; Liu Y; Zhu J; Zhang S; Cao X
    J Vet Pharmacol Ther; 2018 Feb; 41(1):e49-e52. PubMed ID: 28892155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tildipirosin in estuarine (Crocodylus porosus) and freshwater (Crocodylus siamensis) crocodiles.
    Poapolathep S; Escudero E; Klangkaew N; Phaochoosak N; Wongwaipairoj T; Marin P; Poapolathep A
    Vet J; 2024 Jun; 305():106130. PubMed ID: 38734403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of oxytetracycline into the nasal secretions and relationship between nasal secretions and plasma oxytetracycline concentrations after oral and intramuscular administration in healthy pigs.
    Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Gustin P
    J Vet Pharmacol Ther; 2011 Apr; 34(2):176-83. PubMed ID: 21395609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on a suitable antibiotic therapy for treating swine brucellosis.
    Dieste-Pérez L; Fraile L; de Miguel MJ; Barberán M; Blasco JM; Muñoz PM
    J Vet Pharmacol Ther; 2015 Aug; 38(4):357-64. PubMed ID: 25413993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children.
    Aarons L; Rowland M; Khan A; Taborelli G; Ferrea G; Tarantino V; Fioredda F; Rosina-Parenti R; Cavenaghi L; Borgonovi M
    Eur J Pharm Sci; 1998 Oct; 6(4):265-70. PubMed ID: 9795079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical disease and lung lesions in calves experimentally inoculated with Histophilus somni five days after metaphylactic administration of tildipirosin or tulathromycin.
    Confer AW; Snider TA; Taylor JD; Montelongo M; Sorensen NJ
    Am J Vet Res; 2016 Apr; 77(4):358-66. PubMed ID: 27027834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses.
    Abu-Basha EA; Bani Ismail Z; Ababneh MM; Hamzeh E; Gehring R
    J Vet Pharmacol Ther; 2021 Jul; 44(4):544-551. PubMed ID: 33609061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of gamithromycin after intravenous and subcutaneous administration in pigs.
    Wyns H; Meyer E; Plessers E; Watteyn A; De Baere S; De Backer P; Croubels S
    Res Vet Sci; 2014 Feb; 96(1):160-3. PubMed ID: 24331716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and intrapulmonary disposition of tilmicosin after single and repeated oral bolus administrations to rabbits.
    Gallina G; Lucatello L; Drigo I; Cocchi M; Scandurra S; Agnoletti F; Montesissa C
    Vet Res Commun; 2010 Jun; 34 Suppl 1():S69-72. PubMed ID: 20480234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing the 16-membered ring macrolides tildipirosin and tilmicosin bound to their ribosomal site.
    Poehlsgaard J; Andersen NM; Warrass R; Douthwaite S
    ACS Chem Biol; 2012 Aug; 7(8):1351-5. PubMed ID: 22563863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration.
    Lombardi KR; Portillo T; Hassfurther R; Hunter RP
    J Vet Pharmacol Ther; 2011 Dec; 34(6):583-7. PubMed ID: 21323676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs.
    Fittipaldi N; Klopfenstein C; Gottschalk M; Broes A; Paradis MA; Dick CP
    Can J Vet Res; 2005 Apr; 69(2):146-50. PubMed ID: 15971680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of tylvalosin and 3-O-acetyltylosin attained in the synovial fluid of swine after administration by oral gavage at 50 and 5 mg/kg.
    Canning P; Bates J; Hammen K; Coetzee J; Wulf L; Rajewski S; Wang C; Karriker L
    J Vet Pharmacol Ther; 2016 Dec; 39(6):621-624. PubMed ID: 27086612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between tylosin and bentonite clay from a pharmacokinetic perspective.
    Devreese M; Osselaere A; Goossens J; Vandenbroucke V; De Baere S; De Backer P; Croubels S
    Vet J; 2012 Dec; 194(3):437-9. PubMed ID: 22749117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.